Author:
Guevara Ángel,Lovato Raquel,Proaño Roberto,Rodriguez-Perez Mario A.,Unnasch Thomas,Cooper Philip J.,Guderian Ronald H.
Funder
Onchocerciasis Elimination Program for the Americas
Ministerio de Salud del Ecuador
Hospital Vozandes de Quito
Chistoffel Blindenmission-Ecuador
The Mectizan Donation Program
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference33 articles.
1. Cupp EW, Mackenzie CD, Unnasch T. The importance of ivermectin to human onchocerciasis: past, present, and the future. Res Rep Trop Med. 2011;2:81–92.
2. Thylefors B. The Mectizan Donation Program (MDP). Ann Trop Med Parasitol. 2008;102(Suppl. 1):39–44.
3. Cupp EW, Bernardo MJ, Kiszewski AE, Collins RC, Taylor HR, Aziz MA, Greene BM. The effects of ivermectin on transmission of Onchocerca volvulus. Science. 1986;231:740–2.
4. Collins RC, Gonzales-Peralta C, Castro J, Zea-Flores G, Cupp MS, Richards FO Jr, Cupp EW. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities. Am J Trop Med Hyg. 1992;47:156–69.
5. World Health Organization. Certification of elimination of human onchocerciasis: criteria and procedures. Geneva: World Health Organization; 2001.
http://apps.who.int/iris/bitstream/handle/10665/66889/WHO_CDS_CPE_CEE_2001.18b.pdf?%20sequence=1&isAllowed=y%20%20p.%201%E2%80%9329
p. 1–29. Accessed 4 Apr 2018.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献